Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 25.45% Profit

June 30, 2023
ELI LILLY AND COMPANY stock recently achieved a significant milestone by reaching the price target forecast set by QuantWave, resulting in a profit of 25.45%. The forecast signal was issued on April 20, 2023, with a price of $368.54 and a predicted long direction. On June 30, 2023, the stock reached the target price of $462.34, confirming the accuracy of the forecast.

This successful prediction highlights the effectiveness of QuantWave's analytical tools in identifying profitable opportunities in the market. In the case of ELI LILLY AND COMPANY, factors such as positive earnings reports, successful product launches, and overall market sentiment likely contributed to the stock's upward movement.

QuantWave's automated forecasting platform provides users with access to reliable predictions for various stocks, presenting potential opportunities for profitable trades. For investors interested in delving deeper into QuantWave's investment strategy, QuantSchool offers a comprehensive educational framework that outlines key principles for generating consistent income through the platform's forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

MMMJuly 26, 20243M COMPANY Stock Hits Price Target Forecast with 27.56% Profit  ~1 min.

On July 9, 2024, QuantWave, an automated forecasting platform, issued a long signal for the stock of 3M COMPANY when it was trading at $97.67....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....

MSFTJuly 18, 2023Successful Price Target Forecast Achieved for Microsoft Corporation With 12.86% Profit  ~1 min.

On May 18, 2023, QuantWave issued a long signal for MICROSOFT CORPORATION stock when it was trading at 313.64 $....

USBApril 3, 2025U.S. BANCORP Stock Hits Price Target with 10.17% Profit - QuantWave Forecasts Success  ~1 min.

U.S. BANCORP stock recently achieved its forecasted price target as predicted by QuantWave, resulting in a profit of 10.17%. The forecast signal date was on March 25, 2025, with a price of 42.71 $....

TGTApril 3, 2025Target Corporation Stock Hits Forecasted Price Target with 9.52% Profit  ~1 min.

On March 20, 2025, QuantWave's forecasting platform issued a signal for Target Corporation's stock, predicting a short direction at a price of 103.02 $....